Skip to content

Compression therapy as a prophylactic method against paclitaxel-induced peripheral neuropathy: a prospective self-controlled trial

Compression therapy as a prophylactic method against paclitaxel-induced peripheral neuropathy: a prospective self-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061791
Enrollment
Unknown
Registered
2022-07-02
Start date
2022-06-20
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

Experimental group:Wear pressurized gloves and foot caps 15 minutes before and 15 minutes after chemotherapy for taxus drugs.
Control group:Without any intervention before and after chemotherapy.

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed patients who have not received antitumor therapy; 2. Nasopharyngeal carcinoma confirmed by pathology; 3. Taxus drugs were included in the chemotherapy regimen; 4. ECOG physical status score: 0-2; 5. Age range from 18 to 70; 6. Laboratory examination results within one week before enrollment should meet the following conditions: neutrophils (ANC) >= 1.5 x 10^9/L, platelets (PLT) >= 80 x10^9/L, total bilirubin (TBI) <= 1.5 x upper limit of normal value (2mg/ dL), ALT and AST <= 2 x upper limit of normal value; 7. Patients voluntarily participate and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with peripheral neuropathy, hand-foot syndrome, and dermatomyositis; 2. Patients with missing fingers or toes; 3. Patients with Raynaud's syndrome and peripheral vascular ischemia; 4. Pregnant or lactating women; 5. Those considered unsuitable for inclusion by the researcher.

Design outcomes

Primary

MeasureTime frame
Incidence of common adverse event evaluation criteria (CTCAE) 5.0 = 2°CIPN after compression prophylaxis with compression gloves and stretch socks.;

Secondary

MeasureTime frame
EORTC QLQ-CIPN20 score;EORTC QLQ-C30 score;NRS score;

Countries

China

Contacts

Public ContactChunyan Chen, Fei Han

Sun Yat-sen University Cancer Center

chenchuny@sysucc.org.cn13826423812, 13822113698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026